These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2006-000228-14 Immunization of disease-free melanoma patients with different HLA-A2 peptides. not-yet-due
Ongoing 2006-000353-21 Comparison of the vasoreactivity and endogenous NO production between the left and right internal mammary 6 months after bypass surgery with the injection of substance P and exogenous nitric oxide. not-yet-due
Ongoing 2006-001780-30 A PHASE II STUDY OF SU011248 IN PATIENTS WITH RECURRENT AND/OR METASTATIC SQUAMOUS HEAD AND NECK CARCINOMA. not-yet-due
Other 2006-003549-18 Reduction of Bone Morbidity Using an Oral Bisphosphonate in Fibrous Dysplasia of Bone not-yet-due
Ongoing 2006-004635-30 A randomized multicentric phase II study of prolonged adjuvant Temozolomide or "stop and go" in glioblastoma patients : the PATSGO study. not-yet-due
Ongoing 2006-004830-34 TACROLIMUS AND PRETRANSPLANT HIGH-DOSE R-ATG INDUCTION VS TACROLIMUS MONOTHERAPY AS TOLEROGENIC IMMUNOSUPPRESSION IN ADULT LIVER TRANSPLANTATION.AN OPEN LABEL, RANDOMISED, PROSPECTIVE AND CONTROLLED T... not-yet-due
Ongoing 2006-005386-19 Cytokines and inflammatory proteins gene expression study in synovial biopsies from rheumatoid arthritis patients refractory to anti-TNF therapy treated with Rituximab not-yet-due
Ongoing 2007-001559-20 Steady-state pharmacokinetics of high dose acetaminophen inpost-op children. Rational use of N-acetyl cysteine for prevention of liver toxicity related to cumulative doses. not-yet-due
Ongoing 2007-002940-86 Sepsis, Endothelial function, and Lipids in critically ill patients with Liver Failure (SELLIFA). Nutritional sub-study : Randomized controlled trial comparing the tolerance on lipid metabolism and sa... not-yet-due
Completed, but no date 2007-003023-20 TACROLIMUS – DACLIZUMAB - MYCOPHENOLATE MOFETIL IMMUNE PROPHYLAXIS IN PEDIATRIC LIVER TRANSPLANTATION. An open, pilot, investigator-driven study in 20 recipients bad-data
Ongoing 2007-003223-20 Temocillin use in intensive care units: A Pharmacokinetic study of 6g per day in conventional administration vs. continuous infusion not-yet-due
Ongoing 2007-004694-26 A Comparative Study Of A 6-Month Infliximab (Remicade) Or Placebo Regimen In Undifferentiated Arthritis At High Risk For The Development Of Rheumatoid Arthritis : Clinical, Radiological (MRI) And Syno... not-yet-due
Ongoing 2007-004911-79 Pharmacodynamics of Fondaparinux subcutaneous versus continuous intravenous infusion in critically ill patients with or without vasopressors. not-yet-due
Exempt 2008-001354-41 Neoadjuvant cetuximab monotherapy followed by surgery in squamous cell carcinoma of head and neck: phase I/II study not-yet-due
Ongoing 2008-003167-39 Effet du fluconazole sur le taux d'anticorps anti-Saccharomyces cerevisiae (ASCSA) après résection chirurgicale pour maladie de Crohn. not-yet-due
Ongoing 2008-004575-21 A single arm, multicenter, phase II trial of RAD001 as monotherapy in the palliative treatment of patient with locally advanced or metastatic transitional cell carcinoma after failure of platinum-base... not-yet-due
Ongoing 2008-004707-59 A phase II study of CP-751,871 in patients with recurrent and/or metastatic squamous head and neck carcinoma not-yet-due
Completed, but no date 2008-008720-33 A one year, open, prospective study on the role of quarterly intravitreal injections of Lucentis 0,5 mg (ranibizumab) in preventing of delaying progression of radiation retinopathy in eyes treated wit... bad-data
Not reported 2009-010759-29 étude clinique sur l’administration de 3 doses de betaméthasone (12mg) à 18 heures d’intervalle lors d’une menace d’accouchement prématuré dans les grossesses gémellaires traitées par Atosiban, plutôt... 2016-07-26 due-trials
Completed, but no date Terminated 2009-011325-14 Phase II Study of Preoperative Panitumumab and External Beam Radiotherapy in Patients with Locally Advanced Rectal Cancer bad-data
Not reported 2009-015237-76 An open label multicentric phase II study of Panitumumab (Vectibix®) in cutaneous squamous cell carcinoma (SCC) 2017-01-17 due-trials
Exempt 2010-018638-29 Phase I/II study of peptide vaccination associated with GM-CT-01, a galactomannan oligomer that inhibits galestin-3, in patients with advanced metastatic melanoma not-yet-due
Not reported 2010-019873-13 Comparative study of the clinical response and cardiorespiratory endurance in early rheumatoid arthritis patients treated with Tociluzimab or Methotrexate Addendum protocol : Global gene expression pr... 2013-09-16 due-trials
Completed, but no date Terminated 2010-019983-35 Phase I-II study of low dose CdA combined with valproic acid (VPA) in previously treated B-cell chronic lymphocytic leukemia (CLL) patients. bad-data
Ongoing 2011-001756-12 Surrogate markers evaluation in pre-demented Alzheimer’s disease patients and healthy elderly controls not-yet-due
Completed, but no date 2011-001938-42 Randomized Phase II Study of CABAZITAXEL versus METHOTREXATE in patients with recurrent or metastatic squamous cell carcinoma of the head and neck previously treated with platinum-based therapy bad-data
Ongoing 2011-003124-12 A prospective phase II study on dose escalation using PET based adaptive IMRT stage II-III non small lung cancer not-yet-due
Ongoing 2011-005174-27 Phase II study of High-Dose Rituximab in High Risk Chronic Lymphocytic Leukemia in Suboptimal Response after Induction Immunochemotherapy not-yet-due
Ongoing 2011-005274-30 Efficacy and safety of a Double Icodextrin Dose in elderly incident CAPD patients on incremental Peritoneal Dialysis therapy: the DIDo study not-yet-due
Ongoing 2011-006085-40 A proof of concept study to evaluate the use of metabonomics and lipidomics in predicting toxicity and efficacy of anti-VEGF therapy in patients with metastatic clear cell renal cell carcinoma. not-yet-due
Ongoing 2012-003314-13 RING – RItuximab for lupus Nephritis with remission not-yet-due
Ongoing 2012-003774-76 Perioperative ketorolac in high risk breast cancer patients with and without inflammation. A prospective randomized placebo-controlled trial. not-yet-due
Completed, but no date Terminated 2012-004123-20 A single arm, multicenter, phase II study of BEZ235 as monotherapy in bad-data
Ongoing 2012-005076-34 Prolonged-release oral Fampridine in Multiple Sclerosis: effects on clinical, neurophysiological and quantified gait analysis parameters. A cross-over, double-blinded, placebo-controlled study. not-yet-due
Completed, but no date Terminated 2012-005249-19 Randomized Phase 2 study comparing pathological responses observed on colorectal cancer metastases resected after preoperative treatment combining cetuximab with FOLFOX or FOLFIRI in RAS and B-RAF WT ... bad-data
Ongoing 2012-005376-34 Randomized Phase 2 study comparing pathological responses observed on colorectal cancer metastases resected after preoperative treatment combining bevacizumab with FOLFOX or FOLFIRI. not-yet-due
Ongoing 2013-000615-24 Tacrolimus disposition in pediatric transplantation: influence of age, not-yet-due
Ongoing 2014-003856-30 Sandostatin (Octreotide LAR) may lead to clinical improvement through receptor occupation optimisation. A prospective interventional trial of patients with neuro-endocrine tumors with carcinoid syndro... not-yet-due
Ongoing 2014-004224-22 Temocillin pharmacokinetics in paediatrics not-yet-due
Ongoing 2014-005170-11 Can we get conscious sedation in optimal safety conditions in an emergency department, by combining dexmedetomidine with alfentanil? not-yet-due
Ongoing 2015-001246-28 Ultrasound scores as imaging biomarkers of early response to subcutaneous tocilizumab in association with methotrexate in early rheumatoid arthritis (TOVERA study) not-yet-due
Ongoing 2015-001703-32 Phase III multicentric study evaluating the efficacy and safety of sirolimus in Vascular Anomalies that are refractory to standard care not-yet-due
Ongoing 2015-003146-75 A multi-centre randomized, placebo-controlled trial of mirabegron, a new beta3-adrenergic receptor agonist on the progression of left ventricular mass and diastolic function in patients with structura... not-yet-due
Ongoing 2016-005062-61 Effects of vitamin D supplementation during a non-surgical treatment of generalized chronic periodontitis: a randomized double-blinded placebo-controlled clinical trial not-yet-due
Ongoing 2017-001619-35 Exploratory pathophysiological study in five patients suffering from new-onset lupus nephritis and treated with rituximab as first-line treatment not-yet-due
Ongoing 2017-002007-97 Does LOW Dose DEXmedetomidine After Cardiopulmonary Bypass Separation not-yet-due
Ongoing 2017-002473-19 PREDICTIVE FACTORS AND MAGNITUDE OF RESPONSE TO OMALIZUMAB AND MEPOLIZUMAB IN ALLERGIC AND EOSINOPHILIC SEVERE ASTHMA: not-yet-due
Ongoing 2017-002532-16 Adjunctive systemic antimicrobial therapy in the surgical treatment of peri-implantitis. A prospective randomized clinical study not-yet-due
Ongoing 2017-004493-34 Evaluation of multiple subgingival irrigations with 10% povidone iodine after scaling and root planing : a randomized clinical trial not-yet-due
Ongoing 2018-001096-20 Avelumab combined with cetuximab and irinotecan for treatment refractory metastatic colorectal microsatellite stable cancer – A proof of concept, open label non-randomized Phase IIa study. not-yet-due
Ongoing 2018-002499-42 Evaluation of the effect of repeated injections of high doses of botulinum toxin into the lower limb of spastic brain lesions on functional and biomechanical parameters of walking not-yet-due